SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-231543
Filing Date
2023-09-08
Accepted
2023-09-08 16:10:54
Documents
14
Period of Report
2023-09-08
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d534790d8k.htm   iXBRL 8-K 30318
2 EX-99.1 d534790dex991.htm EX-99.1 13308
6 GRAPHIC g534790g0908230335206.jpg GRAPHIC 3895
  Complete submission text file 0001193125-23-231543.txt   184962

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vigl-20230908.xsd EX-101.SCH 2859
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vigl-20230908_lab.xml EX-101.LAB 19500
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vigl-20230908_pre.xml EX-101.PRE 12162
8 EXTRACTED XBRL INSTANCE DOCUMENT d534790d8k_htm.xml XML 3606
Mailing Address 100 FORGE ROAD SUITE 700 WATERTOWN MA 02472
Business Address 100 FORGE ROAD SUITE 700 WATERTOWN MA 02472 857-254-4445
Vigil Neuroscience, Inc. (Filer) CIK: 0001827087 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41200 | Film No.: 231245382
SIC: 2836 Biological Products, (No Diagnostic Substances)